BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 33029937)

  • 1. Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
    Kerkmeijer LSM; Chandrasekhar J; Kalkman DN; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; van 't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
    Catheter Cardiovasc Interv; 2021 Sep; 98(3):503-510. PubMed ID: 33029937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year clinical outcomes after dual-therapy COMBO stent placement: Insights from the REMEDEE registry.
    Kalkman DN; Kerkmeijer LS; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; van 't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
    Catheter Cardiovasc Interv; 2019 Sep; 94(3):342-347. PubMed ID: 30565371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration.
    de Winter RJ; Chandrasekhar J; Kalkman DN; Aquino MB; Woudstra P; Beijk MA; Sartori S; Baber U; Tijssen JG; Koch KT; Dangas GD; Colombo A; Mehran R; ;
    JACC Cardiovasc Interv; 2018 Oct; 11(19):1969-1978. PubMed ID: 30286855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Performance of the COMBO Dual-Therapy Stent: Results from the REMEDEE Registry.
    Kerkmeijer LS; Kalkman DN; Woudstra P; Menown IBA; Suryapranata H; den Heijer P; Iñiguez A; Van't Hof AWJ; Erglis A; Arkenbout KE; Muller P; Koch KT; Tijssen JG; Beijk MAM; de Winter RJ
    Cardiovasc Revasc Med; 2020 May; 21(5):567-570. PubMed ID: 31662276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1-Year Results of the REMEDEE Registry: Clinical Outcomes After Deployment of the Abluminal Sirolimus-Coated Bioengineered (Combo) Stent in a Multicenter, Prospective All-Comers Registry.
    Woudstra P; Kalkman DN; den Heijer P; Menown IB; Erglis A; Suryapranata H; Arkenbout KE; Iñiguez A; van 't Hof AW; Muller P; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2016 Jun; 9(11):1127-34. PubMed ID: 27209254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of clinical outcomes after COMBO stent treatment in patients presenting with acute coronary syndrome.
    Kalkman DN; Woudstra P; Lu H; Menown IBA; den Heijer P; Suryapranata H; Iñiguez A; Arkenbout KE; Van't Hof AWJ; Muller P; Erglis A; Tijssen JG; Beijk MAM; de Winter RJ
    Catheter Cardiovasc Interv; 2017 Aug; 90(2):E31-E37. PubMed ID: 28145609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-Year COMBO Stent Outcomes in Acute Coronary Syndrome: from the COMBO Collaboration.
    Chandrasekhar J; de Winter VC; Kalkman DN; Sartori S; Chandiramani R; Aquino MB; de Wilde P; Zeebregts D; Woudstra P; Beijk MA; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iniguez A; Coufal Z; Lee M; Tijssen JG; Koch KT; Baber U; Dangas GD; Colombo A; de Winter RJ; Mehran R;
    Cardiovasc Drugs Ther; 2021 Apr; 35(2):309-320. PubMed ID: 33515411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of the COMBO bio-engineered stent in an all-comer PCI cohort: 1-Year final clinical outcomes from the MASCOT post-marketing registry.
    Colombo A; Chandrasekhar J; Aquino M; Ong TK; Sartori S; Baber U; Lee M; Iniguez A; Hajek P; Borisov B; Atzev B; Den Heijer P; Coufal Z; Hudec M; Mates M; Snyder C; Moalem K; Morrell D; Elmore F; Rowland S; Mehran R;
    Int J Cardiol; 2019 May; 283():67-72. PubMed ID: 30826192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Year Clinical Outcomes of All Comers Treated With 2 Bioresorbable Polymer-Coated Sirolimus-Eluting Stents: Propensity Score-Matched Comparison of the COMBO and Ultrathin-Strut Orsiro Stents.
    Chandrasekhar J; Kok MM; Kalkman DN; Aquino MB; Zocca P; Woudstra P; Beijk MA; Kerkmeijer LS; Sartori S; Baber U; Tijssen JG; Koch KT; Dangas GD; Colombo A; Pocock S; von Birgelen C; Mehran R; de Winter RJ;
    JACC Cardiovasc Interv; 2020 Apr; 13(7):820-830. PubMed ID: 32273094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early discontinuation of dual antiplatelet therapy in patients treated with the bio-engineered pro-healing sirolimus-eluting (COMBO) stent.
    Kalkman DN; Woudstra P; Menown IBA; Tijssen JG; Beijk MAM; de Winter RJ;
    Cardiovasc Revasc Med; 2018; 19(3 Pt B):373-375. PubMed ID: 29277288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mega COMBO collaboration: An individual patient data pooled analysis of patients undergoing PCI with COMBO stent.
    Nardin M; Pivato CA; Cao D; Sartori S; Zhang Z; Vogel B; Nicolas J; Chiarito M; Qiu H; Chandrasekhar J; Spirito A; Abizaid A; Christiansen EH; Colombo A; de Winter RJ; Haude M; Jakobsen L; Jensen LO; Krucoff MW; Landmesser U; Saito S; Suryapranata H; De Luca G; Dangas G; Mehran R
    Int J Cardiol; 2023 Jan; 370():149-155. PubMed ID: 36270496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Year Outcomes with COMBO Stents in Small-Vessel Coronary Disease: Subgroup Analysis From the COMBO Collaboration.
    Chandrasekhar J; Zeebregts D; Kalkman DN; Sartori S; Roumeliotis A; Aquino MB; de Wilde P; de Winter VC; Baber U; Woudstra P; Beijk MA; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iniguez A; Lee M; Tijssen JG; Koch KT; Dangas GD; Colombo A; Mehran R; de Winter RJ;
    Cardiovasc Revasc Med; 2020 Dec; 21(12):1542-1547. PubMed ID: 32507695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year clinical outcome of biodegradable polymer sirolimus-eluting stent in diabetic patients: Insight from the ULISSE registry (ULtimaster Italian multicenter all comerS Stent rEgistry).
    Beneduce A; Ferrante G; Ielasi A; Pivato CA; Chiarito M; Cappelletti A; Baldetti L; Magni V; Prati E; Falcone S; Pierri A; De Martini S; Montorfano M; Parisi R; Rutigliano D; Locuratolo N; Anzuini A; Tespili M; Margonato A; Benassi A; Briguori C; Reimers B; Fabbiocchi F; Bartorelli A; Colombo A; Godino C
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):255-265. PubMed ID: 31905259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-year results after PCI with the COMBO stent in all-comers in Asia versus Europe: Geographical insights from the COMBO collaboration.
    Chandrasekhar J; Kalkman DN; Aquino MB; Sartori S; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iñiguez A; Coufal Z; Khashaba A; Schee A; Munawar M; Gerber RT; Yan BP; Tejedor P; Kala P; Liew HB; Lee M; Baber U; Vogel B; Dangas GD; Colombo A; de Winter RJ; Mehran R; ;
    Int J Cardiol; 2020 May; 307():17-23. PubMed ID: 32111358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.
    Chandrasekhar J; Kerkmeijer LS; Kalkman DN; Sartori S; Aquino MB; Woudstra P; Beijk MA; Tijssen JG; Koch KT; Hájek P; Atzev B; Hudec M; Ong TK; Mates M; Borisov B; Warda HM; den Heijer P; Wojcik J; Iñiguez A; Coufal Z; Khashaba A; Munawar M; Gerber RT; Yan BP; Lee M; Baber U; Dangas GD; Colombo A; de Winter RJ; Mehran R;
    Catheter Cardiovasc Interv; 2021 Apr; 97(5):797-804. PubMed ID: 32198837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everolimus-eluting Xience v/Promus versus zotarolimus-eluting resolute stents in patients with diabetes mellitus.
    Park KW; Lee JM; Kang SH; Ahn HS; Kang HJ; Koo BK; Rhew JY; Hwang SH; Lee SY; Kang TS; Kwak CH; Hong BK; Yu CW; Seong IW; Ahn T; Lee HC; Lim SW; Kim HS
    JACC Cardiovasc Interv; 2014 May; 7(5):471-81. PubMed ID: 24852802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One year clinical outcomes in patients with insulin-treated diabetes mellitus and non-insulin-treated diabetes mellitus compared to non-diabetics after deployment of the bio-engineered COMBO stent.
    Kalkman DN; Woudstra P; den Heijer P; Menown IB; Erglis A; Suryapranata H; Arkenbout KE; Iñiguez A; van 't Hof AW; Muller P; Tijssen JG; de Winter RJ
    Int J Cardiol; 2017 Jan; 226():60-64. PubMed ID: 27788391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year clinical results of the NANO registry: A multicenter, prospective all-comers registry study in patients receiving implantation of a polymer-free sirolimus-eluting stent.
    Liu Y; Zhang Y; Li Y; Qi T; Pan D; Wang H; Liu C; Ma D; Fang Z; Zhang R; Mou F; Tao L;
    Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():658-664. PubMed ID: 31961057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The REMEDEE trial: 5-Year results on a novel combined sirolimus-eluting and endothelial progenitor cells capturing stent.
    Haude M; Lee SWL; Worthley SG; Silber S; Verheye S; Rosli MA; Botelho R; Sim KH; Abizaid A; Mehran R;
    Catheter Cardiovasc Interv; 2020 May; 95(6):1076-1084. PubMed ID: 31489742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of a novel abluminal groove-filled biodegradable polymer sirolimus-eluting stent for the treatment of de novo coronary lesions: Final five-year results of the patient-level pooled analysis from the TARGET I and TARGET II trials.
    Li C; Guan C; Zhang R; Yang Y; Ma C; Li H; Chen S; Han Y; Xu B; Gao R;
    Catheter Cardiovasc Interv; 2019 Feb; 93(S1):818-824. PubMed ID: 30565397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.